C van der Veer1, M S van Rooijen2, M Himschoot1, H J C de Vries3, S M Bruisten1. 1. Public Health Laboratory, GGD Amsterdam, Amsterdam, The Netherlands. 2. STI Clinic, GGD Amsterdam, Amsterdam, The Netherlands. 3. STI Clinic, GGD Amsterdam, Amsterdam, The Netherlands Department of Dermatology, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands Centre for Infection and Immunity Amsterdam (CINIMA), Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands.
Abstract
BACKGROUND: Men are not routinely tested for Trichomonas vaginalis (TV) and Mycoplasma genitalium (MG) in the Netherlands and, therefore, very few studies have looked into their prevalence and/or role in urogenital complaints in the Dutch male population. OBJECTIVE: To describe the age-specific prevalence and disease burden of TV and MG, and their co-occurrence with Chlamydia trachomatis (CT), in men attending the sexually transmitted infections (STI) clinic in Amsterdam, the Netherlands. METHODS: Urine samples and clinical data were collected from 526 men who have sex with women (MSW) and 678 men who have sex with men (MSM) attending the STI clinic. To investigate age as a risk factor, we oversampled older men. Urine samples were tested for TV and MG using molecular tests. RESULTS: The overall prevalence was 0.5% (6/1204) for TV and 3.1% (37/1204) for MG. Four out of the six TV cases were older than 40 years and all TV cases were MSW. No age trend was observed for MG, nor did MG prevalence differ between MSW and MSM. Co-infections between TV or MG and CT were rare. TV infection did not associate with urogenital symptoms, whereas 5.9% of men reporting urogenital symptoms were infected with MG. CONCLUSIONS: TV infection was rare in men, asymptomatic and was limited to the heterosexual network. MG infection was relatively common and equally prevalent among MSW and MSM of all ages. Most MG infections remained asymptomatic, however, our results suggest that up to 6% of urogenital complaints could be explained by MG infection. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/
BACKGROUND:Men are not routinely tested for Trichomonas vaginalis (TV) and Mycoplasma genitalium (MG) in the Netherlands and, therefore, very few studies have looked into their prevalence and/or role in urogenital complaints in the Dutch male population. OBJECTIVE: To describe the age-specific prevalence and disease burden of TV and MG, and their co-occurrence with Chlamydia trachomatis (CT), in men attending the sexually transmitted infections (STI) clinic in Amsterdam, the Netherlands. METHODS: Urine samples and clinical data were collected from 526 men who have sex with women (MSW) and 678 men who have sex with men (MSM) attending the STI clinic. To investigate age as a risk factor, we oversampled older men. Urine samples were tested for TV and MG using molecular tests. RESULTS: The overall prevalence was 0.5% (6/1204) for TV and 3.1% (37/1204) for MG. Four out of the six TV cases were older than 40 years and all TV cases were MSW. No age trend was observed for MG, nor did MG prevalence differ between MSW and MSM. Co-infections between TV or MG and CT were rare. TVinfection did not associate with urogenital symptoms, whereas 5.9% of men reporting urogenital symptoms were infected with MG. CONCLUSIONS:TVinfection was rare in men, asymptomatic and was limited to the heterosexual network. MG infection was relatively common and equally prevalent among MSW and MSM of all ages. Most MG infections remained asymptomatic, however, our results suggest that up to 6% of urogenital complaints could be explained by MG infection. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/
Entities:
Keywords:
INFECTIOUS DISEASES; MALES; NON SPECIFIC URETHIUS
Authors: Thomas Trevis; Marianne Gossé; Nicola Santarossa; Sepehr Tabrizi; Darren Russell; William John McBride Journal: PLoS One Date: 2018-08-28 Impact factor: 3.240
Authors: Juliën N A P Wijers; Christian J P A Hoebe; Geneviève A F S van Liere; Petra F G Wolffs; Nicole H T M Dukers-Muijrers Journal: PLoS One Date: 2019-04-19 Impact factor: 3.240
Authors: Joyce F Braam; David J Hetem; Clarissa E Vergunst; Sophie Kuizenga Wessel; Martijn S van Rooijen; Roel H T Nijhuis; Maarten F Schim van der Loeff; Alje P van Dam; Sylvia M Bruisten Journal: PLoS One Date: 2020-10-20 Impact factor: 3.240
Authors: Giovanna Cowley; Gregory Milne; Eunice Teixeira da Silva; Jose Nakutum; Amabelia Rodrigues; Hristina Vasileva; David Mabey; Bart Versteeg; Anna Last Journal: Sex Transm Infect Date: 2020-04-28 Impact factor: 3.519
Authors: Olivia T Van Gerwen; Andres F Camino; Jyoti Sharma; Patricia J Kissinger; Christina A Muzny Journal: Clin Infect Dis Date: 2021-09-15 Impact factor: 20.999